When combining immunotherapy and targeted therapy, one major rationale is:
Show answer and explanation
Correct answer: To exploit synergy by attacking cancer via different mechanisms
Combining immunotherapy and targeted therapy may improve outcomes by using immune-mediated attack plus inhibition of cancer growth pathways.
Practice all 20 Immunotherapy and Targeted Therapy questions
Keep practicing
More Immunotherapy and Targeted Therapy questions
- Which scenario best illustrates adoptive cell transfer immunotherapy (such as CAR T-cell therapy)?
- For a patient receiving checkpoint inhibitor immunotherapy, which of the following side-effects should the nurse monitor for?
- Which statement about monoclonal antibodies used in targeted therapy is correct?
- A small-molecule targeted therapy differs from a monoclonal antibody because:
- Which of the following is true regarding patient selection for targeted therapy?
- The term “durable response” in cancer immunotherapy means: